26 Jan Case Study: Applying GLPs to New, Non-Animal Methodologies
Presented at the 2nd Good Laboratory Practice Compliance Summit, January 26-27, 2017, Arlington, VA...
Author: Jane Ryan
26 Jan IIVS Director of Quality & Compliance to Present on GLPs
Amanda Ulrey, RQAP-GLP, IIVS Director of Quality & Compliance, will be presenting at the 2nd Good Laboratory Practice Compliance Summit and the SQA Annual Meeting & Quality College. Jan. 26-27, 2018: 2nd Good Laboratory Practice Compliance Summit “Case Study: Applying GLPs to New, Non-Animal Assays” Mar. 26-31: SQA...
24 Jan In Vitro Assessment of Skin Irritation Potential of Surfactant-based Formulations by Using a 3-D Skin Reconstructed Tissue Model and Cytokine Response
The personal care industry is focused on developing safe, more efficacious, and increasingly milder products, that are routinely undergoing preclinical and clinical testing before becoming available for consumer use on skin. In vitro systems based on skin reconstructed equivalents are now established for the preclinical...
23 Jan PETA: New Chinese Regulations Will Effectively End Animal Testing Requirement for Non-Special Use Cosmetics
PETA Senior Vice President Kathy Guillermo has issued a statement in response to a new regulation issued by China's Food and Drug Administration's (CFDA), which allows certain new cosmetics to undergo a simplified registration process with the Shanghai Food and Drug Administration, potentially allowing them...
18 Jan Switzerland Joins Fight on Animal Cruelty with Ban on Animal-Tested Cosmetics
Switzerland has announced a complete ban on sales of cosmetics that are tested on animals. The decision follows the announcement in March last year by the Swiss Federal Council that saw it ban the marketing of cosmetics that have been tested on animals abroad, with...
12 Jan 2017 Practical Methods for In Vitro Toxicology Workshop Wraps Up
IIVS welcomed twelve individuals from industry and academia for its 2017 Practical Methods in In Vitro Toxicology Workshop. The intensive four-day workshop included a combination of lectures and hands-on laboratory activities on the latest in vitro test methods. The next workshop will be held in January...
10 Jan The Use of Human 3D Reconstructed Airway Cultures for Tobacco Product Evaluation: Precision Low-Volume Exposures at the Apical Site
With a mandate to evaluate the dynamics of pulmonary exposure to inhaled materials such as tobacco-based products, researchers are employing complex, human, three-dimensional pulmonary models. Human reconstructed airway (RHuA) tissues present a platform that more closely resembles airways in vivo. Grown at the air–liquid interface (ALI), RHuA tissues...
28 Dec Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization
Vitiligo is the most frequent human pigmentary disorder, characterized by progressive autoimmune destruction of mature epidermal melanocytes. Of the current treatments offering partial and temporary relief, ultraviolet (UV) light is the most effective, coordinating an intricate network of keratinocyte and melanocyte factors that control numerous...
22 Dec EPA Announces Start of Voluntary Pilot Program to Reduce Animal Testing
On December 20, 2016, the U.S. Environmental Protection Agency (EPA)announced the start of a pilot program to evaluate the usefulness and acceptability of a mathematical tool (the GHS Mixtures Equation), which is used in the Globally Harmonized System of Classification and Labeling of Chemicals (GHS)....
22 Dec Dutch Government Announces Plan to Phase Out Animal Safety Testing by 2025
PETA UK and PETA Netherlands staff attended a meeting in Hague last week at which Dutch Secretary of State for Economic Affairs Martijn van Dam announced his intention for the Netherlands to end the use of animals in safety tests for chemicals, food ingredients, pesticides,...